| Line Item | 2023-04-28 | Y/Y |
|---|---|---|
| Revenue | $31.23B | -1.4% |
| Cost of Revenue | $10.72B | +5.7% |
| R&D Expense | $2.70B | -1.8% |
| SG&A Expense | $10.41B | +1.2% |
| Operating Income | $5.49B | -4.6% |
| Interest Expense | $636.0M | +15.0% |
| Pre-tax Income | $5.36B | -2.8% |
| Income Tax | $1.58B | +246.5% |
| Net Income | $3.76B |
| Line Item | 2023-04-28 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.54B | -58.5% |
| Short-term Investments | $6.42B | -6.5% |
| Accounts Receivable | $6.00B | +8.1% |
| Inventory | $5.29B | +14.7% |
| Current Assets | $21.68B | -6.0% |
| Total Assets | $90.95B | -0.0% |
| Current Liabilities | $9.05B | -27.0% |
| Line Item | 2023-04-28 | Y/Y |
|---|---|---|
| Operating Cash Flow | $6.04B | -17.8% |
| Capital Expenditures | $1.46B | +6.7% |
| Investing Cash Flow | -$3.49B | -110.5% |
| Financing Cash Flow | -$4.96B | +7.0% |
| Free Cash Flow | $4.58B | -23.4% |
| -25.4% |
| EPS (Basic) | $2.83 | -24.5% |
| EPS (Diluted) | $2.82 | -24.4% |
| Long-term Debt |
| $24.34B |
| +19.5% |
| Total Liabilities | $39.28B | +2.7% |
| Stockholders' Equity | $51.48B | -2.0% |